High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Top Cited Papers
- 27 September 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 120 (13), 2700-2703
- https://doi.org/10.1182/blood-2012-05-430140
Abstract
Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis. BRAF mutations have been observed in Langerhans cell histiocytosis (LCH). We investigated the frequency of BRAF mutations in several types of histiocytoses. Histology from 127 patients with histiocytoses were reviewed. Detection of BRAFV600 mutations was performed by pyrosequencing of DNA extracted from paraffin embedded samples. Diagnoses of Erdheim-Chester disease (ECD), LCH, Rosai-Dorfman disease, juvenile xanthogranuloma, histiocytic sarcoma, xanthoma disseminatum, interdigitating dendritic cell sarcoma, and necrobiotic xanthogranuloma were performed in 46, 39, 23, 12, 3, 2, 1, and 1 patients, respectively. BRAF status was obtained in 93 cases. BRAFV600E mutations were detected in 13 of 24 (54%) ECD, 11 of 29 (38%) LCH, and none of the other histiocytoses. Four patients with ECD died of disease. The high frequency of BRAFV600E in LCH and ECD suggests a common origin of these diseases. Treatment with vemurafenib should be investigated in patients with malignant BRAFV600E histiocytosis.Keywords
This publication has 18 references indexed in Scilit:
- B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric DiseasePLOS ONE, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationThe New England Journal of Medicine, 2011
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyActa Neuropathologica, 2011
- CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patientsBlood, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004Pediatric Blood & Cancer, 2008
- Raf: A Strategic Target for Therapeutic Development Against CancerJournal of Clinical Oncology, 2005
- Mutations of the BRAF gene in human cancerNature, 2002
- Definitive Diagnosis with the Use of Monoclonal Antibody O10 on Routinely Paraffin-embedded SamplesThe American Journal of Surgical Pathology, 1995
- HISTIOCYTOSIS SYNDROMES IN CHILDRENThe Lancet, 1987